Theratechnologies Inc. - Common Shares (THTX)

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Common Shares
Shares outstanding
46M
Number of holders
27
Total 13F shares, excl. options
15.1M
Shares change
+8.83M
Total reported value, excl. options
$24.5M
Value change
+$14.3M
Number of buys
12
Number of sells
-7
Price
$1.62

Significant Holders of Theratechnologies Inc. - Common Shares (THTX) as of Q4 2023

31 filings reported holding THTX - Theratechnologies Inc. - Common Shares as of Q4 2023.
Theratechnologies Inc. - Common Shares (THTX) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 15.1M shares of 46M outstanding shares and own 32.95% of the company stock.
Largest 10 shareholders include Soleus Capital Management, L.P. (4.8M shares), AIGH Capital Management LLC (3.72M shares), Nantahala Capital Management, LLC (2.68M shares), MORGAN STANLEY (2.26M shares), Worth Venture Partners, LLC (907K shares), OSAIC HOLDINGS, INC. (128K shares), NATIONAL BANK OF CANADA /FI/ (113K shares), Cyndeo Wealth Partners, LLC (104K shares), STIFEL FINANCIAL CORP (69.1K shares), and Federation des caisses Desjardins du Quebec (54.3K shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.